FDA Clears Philips Spectral CT Diagnostic Suite

Imaging Technology News·Sep 9

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA has cleared a Philips spectral CT diagnostic suite. The clearance appears to involve multiple related products, including the Verida AI-powered detector-based spectral CT and the Spectral CT 7500, with potential applications in various clinical areas, including radiation oncology and cardiac imaging. The specific details and scope of the clearance are not entirely clear, with different outlets reporting on different aspects of the technology.

Full coverage

Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications

Philips·Apr 16

Philips Gets FDA Nod for Verida AI-powered Detector-based Spectral CT

Imaging Technology News·Apr 20

Philips Introduces the new Spectral CT 7500 as Workhorse Scanner With Spectral Data on Every Scan

dicardiology.com·May 27

Fetching the latest headlines…

FDA Clears Philips Spectral CT Diagnostic Suite

Full coverage

Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications

Philips Gets FDA Nod for Verida AI-powered Detector-based Spectral CT

Philips Introduces the new Spectral CT 7500 as Workhorse Scanner With Spectral Data on Every Scan

Spectral CT System Gets FDA Clearance for Radiation Oncology Use

Philips receives FDA 510(k) clearance for Elevate Plus

FDA Clears Philips IQon Spectral CT

New Technology Supports CT as Prime Cardiac Imaging Modality

Philips Spectral CT 7500 RT Receives FDA 510(k) Clearance